Back to the main directory
EarningsReview / Equity
- FQ3’25 postview: organic trajectory relief, ARR in max focus by BNP Paribas Exane
- Guidance raised, deal flow increasing along with B/S strength by BNP Paribas Exane
- No Holes Here by BNP Paribas Exane
- H125 results and call: FY25e guidance reiterated after slow start, c. -2% risk to consensus on ambitious H225e margin views by BNP Paribas Exane
- A Mott-ley quarter by BNP Paribas Exane
- Stellar print, but some caution into an uncertain macro by BNP Paribas Exane
- 2Q results first read by BNP Paribas Exane
- Merlin Properties - Great 2Q25 underpins our positive stance, reiterating Buy by JB Capital Markets
- Solid results/guide, but smartphone backdrop tricky by BNP Paribas Exane
- Broadly in line: first take by BNP Paribas Exane
- Q2 2025 First take by BNP Paribas Exane
- Vyvgart beats expectations by 10% in 2Q25 by BNP Paribas Exane
- Q225 results: material vol miss by BNP Paribas Exane
- HUL 1QFY26: Sales in-line; margins tad below; commentary positive by BNP Paribas Exane
- A mixed bag by BNP Paribas Exane
- Full Q2 release: Solid margin and FCF by BNP Paribas Exane
- Solid Q2 with strong FCF generation by BNP Paribas Exane
- “demand still outstrips supply”. META CEO on 2Q25 call by BNP Paribas Exane
- Q2’25 First Take: Q2 growth miss, cuts FY guide on weaker demand by BNP Paribas Exane
- Small EBITDA beat but Online revenue misses by BNP Paribas Exane
- Sanoma - Strong H1 leaves upside for H2 ahead of bumper 2026 by Danske Bank Equity Research
- Q2 2025 First take by BNP Paribas Exane
- Q2 25 results beat expectations by BNP Paribas Exane
- FY guidance confirmed, CEO appointment by BNP Paribas Exane
- Operating result in line, Chemical margins and sales volume guidance raised, refining margins still very strong by BNP Paribas Exane